Two Leading Biotech Publications Report On Advaxis' Potential Treatment For Cervical Cancer

This news article has expired. Below you will find a short description about the news article and comments that were left by CancerCompass users.

Two leading biotech publications reported that Advaxis, Inc. (ADXS.OB) successfully demonstrated in testing of mice at the University of Pennslyvania that a live listeria vaccine can eradicate existing, rapidly-growing breast tissue tumors.

 

0 Comments

You must be logged in to post comments.

We care about your feedback. Let us know how we can improve your CancerCompass experience.